-
-
-
-
-
-
-
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Misses Q2 EPS by 2c, provides guidance
-
-
-
-
-
-
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Completes License Deal with TG Therapeutics (TGTX) for Cell Therapy Azer-Cel
-
-
-
-
-
-
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

